ICAM-1-Decorated Extracellular Vesicles Loaded with miR-146a and Glut1 Drive Immunomodulation and Hinder Tumor Progression in a Murine Model of Breast Cancer

Investigators reported on a novel nanotechnology-based approach to target tumor-associated immune cells and promoted “anti-tumor” responses in a murine model of breast cancer.